The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions
Open Access
- 19 November 1998
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (5) , 1366-1370
- https://doi.org/10.1016/s0735-1097(98)00376-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Myonecrosis After Revascularization ProceduresJournal of the American College of Cardiology, 1998
- ‘Optimal’ Directional Coronary AtherectomyCirculation, 1998
- Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary AngioplastyCirculation, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE studyThe Lancet, 1997
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IIThe Lancet, 1997
- The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization ProceduresCirculation, 1996
- Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.Heart, 1996
- Letters to the editorCatheterization and Cardiovascular Diagnosis, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994